“…In addition to these suggestions and the general limitations, disruptions of everyday activities and reduced access to health care and therapists might further complicate the situation of people with Parkinson’s disease (PwP) during the COVID-19 pandemic. Global and regional studies from America (US, Canada, Brazil), Asia (China, Japan, South Korea, India, Iran Israel, Turkey), North Africa (Egypt), or European countries (Luxembourg, Netherlands, UK, Italy, Spain, Slovenia) reported wide-ranging consequences of the pandemic on PwP, such as worsened motor and non-motor symptoms [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 ], a negative impact on mental health [ 29 ], a decline in quality of life [ 20 , 21 , 30 ], disrupted social and medical activities [ 12 , 13 ], impaired access to PD medication [ 21 , 31 , 32 ], or other unmet needs such as emotional distress, problems with rescheduling appointments with health care providers, and reduction in physical activity [ 2 , 14 , 20 , 22 , 24 , 33 , 34 ]. On the other side, although hours of caregiving at home and caregiver burden increased [ 33 ], patients and caregivers seem to be well informed and to have coped well in some studies [ 35 , 36 , 37 ].…”